香港股市 將收市,收市時間:4 小時 18 分鐘

Merck & Co., Inc. (MRK)

NYSE - NYSE 延遲價格。貨幣為 USD。
加入追蹤清單
88.390.00 (0.00%)
收市價: 04:03PM EDT
88.85 +0.46 (+0.52%)
收市後: 07:59PM EDT
全螢幕
交易股價資料並非來自所有市場
前收市價88.39
開市88.58
買盤86.89 x 1000
賣出價88.70 x 1000
今日波幅88.02 - 88.78
52 週波幅71.50 - 95.72
成交量5,871,008
平均成交量8,086,440
市值223.917B
Beta 值 (5 年,每月)0.34
市盈率 (最近 12 個月)13.49
每股盈利 (最近 12 個月)6.55
業績公佈日2022年10月27日
遠期股息及收益率2.76 (3.12%)
除息日2022年9月14日
1 年預測目標價100.90
  • Insider Monkey

    10 Healthcare Stocks to Watch in Light of Biden’s ‘60 Minutes’ Interview

    In this article, we will be taking a look at the 10 healthcare stocks to watch in light of Biden’s 60 Minutes interview. To skip our detailed analysis of these stocks and Biden’s insights, you can go directly to see the 5 Healthcare Stocks to Watch in Light of Biden’s 60 Minutes Interview. On September […]

  • Insider Monkey

    10 Best Diversified Dividend Stocks to Buy Now

    In this article, we discuss 10 best diversified dividend stocks to buy now. You can skip our detailed analysis of best dividend stocks and their returns over the years, and go directly to read 5 Best Diversified Dividend Stocks to Buy Now. In September, the S&P 500 reported its largest percentage drop in 20 years, […]

  • Benzinga

    Merck Inks Supply Deal With Sinopharm To Commercialize COVID-19 Pills In China

    Merck & Co Inc (NYSE: MRK) signed a cooperation framework agreement in China for its COVID-19 antiviral pills, which were co-developed by Ridgeback Therapeutics. The pharma giant has granted Sinopharm exclusive import and distribution rights to Lagevrio (molnupiravir). The companies will also negotiate the feasibility of a technical transfer under the framework so that the drug Molnupiravir could be produced and provided in the Chinese mainland market, Global Times reported. While Pfizer's pills